Transgene to present multiple posters highlighting the potential of its exciting immunotherapy pipeline at AACR2023 15
Category: TG6050-en
Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration
Transgene recieves approval to start a Phase I trial of TG6050 15